[go: up one dir, main page]

ES2068151B1 - Microespuma inyectable para esclerosis. - Google Patents

Microespuma inyectable para esclerosis.

Info

Publication number
ES2068151B1
ES2068151B1 ES09301413A ES9301413A ES2068151B1 ES 2068151 B1 ES2068151 B1 ES 2068151B1 ES 09301413 A ES09301413 A ES 09301413A ES 9301413 A ES9301413 A ES 9301413A ES 2068151 B1 ES2068151 B1 ES 2068151B1
Authority
ES
Spain
Prior art keywords
microfoam
injectable
micros
sclerosis
foam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES09301413A
Other languages
English (en)
Other versions
ES2068151A1 (es
Inventor
Garrido Juan Ramon Cabrera
Garcia-Olmedo Juan Cabrera
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8282315&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2068151(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Priority to ES09301413A priority Critical patent/ES2068151B1/es
Priority to AU70012/94A priority patent/AU7001294A/en
Priority to ES94918886T priority patent/ES2131689T7/es
Priority to DK94918886T priority patent/DK0656203T3/da
Priority to PCT/ES1994/000064 priority patent/WO1995000120A1/es
Priority to AT94918886T priority patent/ATE179598T1/de
Priority to EP94918886A priority patent/EP0656203B3/en
Priority to DE69418286T priority patent/DE69418286T2/de
Priority to US08/407,595 priority patent/US5676962A/en
Publication of ES2068151A1 publication Critical patent/ES2068151A1/es
Publication of ES2068151B1 publication Critical patent/ES2068151B1/es
Application granted granted Critical
Priority to GR990401341T priority patent/GR3030248T3/el
Priority to US10/458,806 priority patent/USRE38919E1/en
Priority to US10/941,013 priority patent/USRE40640E1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/07—Microporous membranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

MICROESPUMA INYECTABLE PARA ESCLEROSIS. PROCEDIMIENTO PARA LA ELABORACION DE MICROESPUMA INYECTABLE PARA USOS TERAPEUTICOS. LA ESCLEROSIS DE VARICES SE BASA EN LA INYECCION DE SUSTANCIAS LIQUIDAS DE CONOCIDA CAPACIDAD PARA SUPRIMIRLAS. LA PRESENTE INVENCION SE REFIERE A LA PREPARACION DE SUSTANCIAS ESCLEROSANTES EN FORMA DE MICROESPUMA. AL ELABORAR LA MICROESPUMA CON ESCLEROSANTES, Y SU POSTERIOR INYECCION EN LA VENA A TRATAR, ESTA MICROESPUMA DESPLAZA LA SANGRE QUE CONTIENE LA VENA Y GARANTIZA EL CONTACTO DEL ESCLEROSANTE CON EL ENDOTELIO DEL VASO, A CONCENTRACION CONOCIDA Y DURANTE UN TIEMPO CONTROLABLE.
ES09301413A 1993-06-23 1993-06-23 Microespuma inyectable para esclerosis. Expired - Lifetime ES2068151B1 (es)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ES09301413A ES2068151B1 (es) 1993-06-23 1993-06-23 Microespuma inyectable para esclerosis.
EP94918886A EP0656203B3 (en) 1993-06-23 1994-06-21 Injectable microfoam containing a sclerosing agent
ES94918886T ES2131689T7 (es) 1993-06-23 1994-06-21 Microespuma inyectable que contiene un agente esclerosante.
DK94918886T DK0656203T3 (da) 1993-06-23 1994-06-21 Injicerbart mikroskum indeholdende et scleroserende middel
PCT/ES1994/000064 WO1995000120A1 (es) 1993-06-23 1994-06-21 Microespuma inyectable conteniendo un agente esclerosante
AT94918886T ATE179598T1 (de) 1993-06-23 1994-06-21 Injizierbarer mikroschaum, der ein verödungsmittel enthält
AU70012/94A AU7001294A (en) 1993-06-23 1994-06-21 Injectable microfoam containing a sclerosing agent
DE69418286T DE69418286T2 (de) 1993-06-23 1994-06-21 Injizierbarer Mikroschaum, der ein Verödungsmittel enthält
US08/407,595 US5676962A (en) 1993-06-23 1995-02-23 Injectable microfoam containing a sclerosing agent
GR990401341T GR3030248T3 (en) 1993-06-23 1999-05-19 Injectable microfoam containing a sclerosing agent.
US10/458,806 USRE38919E1 (en) 1993-06-23 2003-06-11 Injectable microfoam containing a sclerosing agent
US10/941,013 USRE40640E1 (en) 1993-06-23 2004-09-15 Injectable microfoam containing a sclerosing agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09301413A ES2068151B1 (es) 1993-06-23 1993-06-23 Microespuma inyectable para esclerosis.

Publications (2)

Publication Number Publication Date
ES2068151A1 ES2068151A1 (es) 1995-04-01
ES2068151B1 true ES2068151B1 (es) 1995-11-16

Family

ID=8282315

Family Applications (2)

Application Number Title Priority Date Filing Date
ES09301413A Expired - Lifetime ES2068151B1 (es) 1993-06-23 1993-06-23 Microespuma inyectable para esclerosis.
ES94918886T Active ES2131689T7 (es) 1993-06-23 1994-06-21 Microespuma inyectable que contiene un agente esclerosante.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES94918886T Active ES2131689T7 (es) 1993-06-23 1994-06-21 Microespuma inyectable que contiene un agente esclerosante.

Country Status (9)

Country Link
US (3) US5676962A (es)
EP (1) EP0656203B3 (es)
AT (1) ATE179598T1 (es)
AU (1) AU7001294A (es)
DE (1) DE69418286T2 (es)
DK (1) DK0656203T3 (es)
ES (2) ES2068151B1 (es)
GR (1) GR3030248T3 (es)
WO (1) WO1995000120A1 (es)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2068151B1 (es) 1993-06-23 1995-11-16 Cabrera Garrido Juan Microespuma inyectable para esclerosis.
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
AU2005205772B2 (en) * 1999-05-26 2009-04-30 Btg International Limited Generation of Therapeutic Microfoam
GB9912356D0 (en) * 1999-05-26 1999-07-28 Btg Int Ltd Generation of microfoam
AU6124601A (en) 2000-05-10 2001-11-20 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US20030120256A1 (en) * 2001-07-03 2003-06-26 Syntheon, Llc Methods and apparatus for sclerosing the wall of a varicose vein
US7077836B2 (en) * 2000-07-21 2006-07-18 Vein Rx, Inc. Methods and apparatus for sclerosing the wall of a varicose vein
GB0028692D0 (en) 2000-11-24 2001-01-10 Btg Int Ltd Generation of therapeutic microform
GB2369996B (en) * 2000-12-18 2004-06-23 S T D Pharmaceutical Products Method and apparatus for producing an injectable foam
US8512680B2 (en) 2001-08-08 2013-08-20 Btg International Ltd. Injectables in foam, new pharmaceutical applications
DE60142311D1 (de) * 2001-08-08 2010-07-15 Dominguez Maria Antonia Garcia-Olmedo Injizierbarer schaum und neue pharmazeutische anwendungen dafür
WO2003053411A1 (en) 2001-12-19 2003-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
AU2003229879A1 (en) * 2002-03-28 2003-10-13 British Telecommunications Public Limited Company Synchronisation in multi-modal interfaces
GB0212047D0 (en) 2002-05-24 2002-07-03 Btg Int Ltd Generation of therapeutic microfoam
GB0300586D0 (en) * 2003-01-10 2003-02-12 Btg Int Ltd Therapeutic microfoam
ES2216708B1 (es) * 2003-04-08 2006-02-16 Antonio Luis Cabrera Garrido "solucion esclerosante".
US7314466B2 (en) * 2003-10-02 2008-01-01 Lary G Banning Minimally invasive vascular surgery
US8048439B2 (en) 2003-11-17 2011-11-01 Btg International Ltd. Therapeutic foam
US7731986B2 (en) 2003-11-17 2010-06-08 Btg International Ltd. Therapeutic foam
ES2247898B1 (es) * 2003-12-18 2006-12-01 Universidad Complutense De Madrid Utilizacion de una inyeccion previa de polidocamol en forma de microespuma para la extirpacion indolora de varices mediante laser.
ITMI20041056A1 (it) * 2004-05-26 2004-08-26 Garrido Antonio Luis Cabrera Uso in campo medico diagnostico e flebo logico di una kiscela di gas sterili e fisiologicamente accettabili
EP1835958A1 (en) * 2005-01-14 2007-09-26 Vein RX Inc. Valve system for a medical device having an inflatable member
GB0509824D0 (en) 2005-05-13 2005-06-22 Btg Int Ltd Therapeutic foam
WO2007114934A2 (en) * 2006-04-04 2007-10-11 Vnus Medical Technologies, Inc. Method and apparatus for generating vascular treatment foam
US9307995B2 (en) * 2006-06-15 2016-04-12 Cook Medical Technologies Llc Methods, systems and devices for the delivery of endoluminal prostheses
US20080050436A1 (en) * 2006-08-25 2008-02-28 Chu Jack F Methods and compounds for obliteration of vessels
US20190070397A1 (en) * 2006-11-27 2019-03-07 Frank Levy Apparatus and method for producing co2 enriched medical foam
CN102950695B (zh) 2006-12-21 2015-05-27 英国技术集团国际有限公司 用于产生治疗性泡沫的装置和方法
WO2009036250A1 (en) * 2007-09-12 2009-03-19 Cook Incorporated Enhanced remodelable materials for occluding bodily vessels and related methods and systems
US8157747B2 (en) 2008-02-15 2012-04-17 Lary Research & Development, Llc Single-use indicator for a surgical instrument and a surgical instrument incorporating same
US10143455B2 (en) 2011-07-20 2018-12-04 Covidien LLP Enhanced ultrasound visualization of intravascular devices
CN102481153B (zh) 2009-02-20 2015-11-25 柯惠有限合伙公司 用于治疗静脉机能不全的静脉闭塞的方法和装置
WO2012170538A2 (en) 2011-06-06 2012-12-13 Cook Medical Technologies Llc Vascular occlusion devices and methods
US8808620B1 (en) 2012-02-22 2014-08-19 Sapheon, Inc. Sterilization process design for a medical adhesive
JP2012246306A (ja) * 2012-08-22 2012-12-13 Btg Internatl Ltd 注射可能な泡製剤および新規な医薬的適用
WO2015105878A1 (en) 2014-01-07 2015-07-16 Covidien Lp Cyanoacrylate compositions including non-agglomerating radiopaque nanoparticles
EP3151951B8 (en) 2014-06-03 2020-08-05 Vascular Barcelona Devices, S.L. Methods, devices, systems and kits for preparing compositions for care and repair of varicose veins
EP2962681A1 (en) 2014-07-03 2016-01-06 Swiss VX Venentherapie und Forschung GmbH Devices and methods for injectable vascular sclerofoams using a carrier made of human blood and uses thereof
US20160045416A1 (en) * 2014-08-14 2016-02-18 John Daniel Dobak Ethanolamine oleate formulations for treatment of adipose tissue
US9687455B2 (en) 2014-08-14 2017-06-27 John Daniel Dobak Sodium tetradecyl sulfate formulations for treatment of adipose tissue
US9351945B1 (en) 2015-02-27 2016-05-31 John Daniel Dobak, III Reduction of adipose tissue
GB201611778D0 (en) 2016-07-06 2016-08-17 Provensis Ltd Method and device for producing foam
GB201612925D0 (en) 2016-07-26 2016-09-07 Provensis Ltd Method and device for generating injectable foam
WO2019178579A1 (en) 2018-03-16 2019-09-19 Boston Scientific Scimed, Inc. Devices for vein closure
IT201800006109A1 (it) 2018-06-07 2019-12-07 Polidocanolo per uso come immunomodulatore
AU2023371657A1 (en) 2022-11-04 2025-05-15 Solvein Inc. Catheters and related methods for aspiration and controlled delivery of closure agents
US20240149020A1 (en) 2022-11-04 2024-05-09 Controlled Delivery Systems, Inc. Catheters for the aspiration controlled delivery of closure agents

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1547768A (fr) 1967-10-09 1968-11-29 Récipient remplissable à dispositif décompresseur
FR2105332A5 (es) 1970-09-01 1972-04-28 Oreal
US3955720A (en) 1972-11-15 1976-05-11 Malone David C Low pressure dispensing apparatus with air pump
US4019657A (en) 1975-03-03 1977-04-26 Spitzer Joseph G Aerosol containers for foaming and delivering aerosols
US3970219A (en) 1975-03-03 1976-07-20 Spitzer Joseph G Aerosol containers for foaming and delivering aerosols and process
US4040420A (en) 1976-04-22 1977-08-09 General Dynamics Packaging and dispensing kit
US4127131A (en) 1977-06-20 1978-11-28 Johnson & Johnson Hub assembly for use in the filtration of fluids and method of making the same
US4276885A (en) 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
US4292972A (en) 1980-07-09 1981-10-06 E. R. Squibb & Sons, Inc. Lyophilized hydrocolloio foam
DE3048744A1 (de) 1980-12-23 1982-07-22 Metzeler Kautschuk GmbH, 8000 München Anordnung zum abdichten einer mehrscheibenverglasung
DE3050812C2 (de) 1980-12-23 1985-03-21 B. Braun Melsungen Ag, 3508 Melsungen Katheterisierungsvorrichtung
DE3048774C2 (de) 1980-12-23 1984-03-08 B. Braun Melsungen Ag, 3508 Melsungen Katheterisierungsvorrichtung
DE3141641A1 (de) * 1981-10-16 1983-04-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen Ultraschall-kontrastmittel und dessen herstellung
US4718433A (en) 1983-01-27 1988-01-12 Feinstein Steven B Contrast agents for ultrasonic imaging
DE3313947A1 (de) 1983-04-15 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen Mikropartikel und gasblaeschen enthaltende ultraschall-kontrastmittel
US5141738A (en) 1983-04-15 1992-08-25 Schering Aktiengesellschaft Ultrasonic contrast medium comprising gas bubbles and solid lipophilic surfactant-containing microparticles and use thereof
DE3324754A1 (de) 1983-07-06 1985-01-17 Schering AG, 1000 Berlin und 4709 Bergkamen Ultraschallkontrastmittel sowie dessen herstellung
DE3417182A1 (de) 1984-05-09 1985-11-14 Gerald Dr. 8000 München Hauer Spritzen-set
GB8522813D0 (en) 1985-09-16 1985-10-23 Unilever Plc Package
DE8704600U1 (de) 1987-03-27 1987-10-15 Cocon Kunststoffen B.V., Arkel Vorrichtung zur gebrauchsfertigen Zubereitung der beiden Komponenten eines zweikomponentigen Montageschaums, insbesondere Polyurethanschaums
IE61591B1 (en) * 1987-12-29 1994-11-16 Molecular Biosystems Inc Concentrated stabilized microbubble-type ultrasonic imaging agent and method of production
CH676456A5 (es) 1988-04-05 1991-01-31 Supermatic Kunststoff Ag
US4957656A (en) 1988-09-14 1990-09-18 Molecular Biosystems, Inc. Continuous sonication method for preparing protein encapsulated microbubbles
US5542935A (en) 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5084011A (en) 1990-01-25 1992-01-28 Grady Daniel J Method for oxygen therapy using hyperbarically oxygenated liquid
US5064103A (en) 1990-05-23 1991-11-12 Rjs Industries, Inc. Foam dispenser having a plurality of sieves
DK0504340T3 (da) * 1990-10-05 1995-08-21 Bracco Int Bv Fremgangsmåde til fremstilling af stabile suspensioner af hule gasfyldte mikrokugler egnet til ultralyd-ekkografi
FR2672038B1 (fr) 1991-01-25 1993-05-14 Oreal Dispositif distributeur de mousse a partir d'un recipient pressurise.
DE4301820C2 (de) 1993-01-23 1996-04-25 Henkel Kgaa Schäumende Emulsionen, Verfahren zu ihrer Herstellung und ihre Verwendung
NL9300517A (nl) 1993-03-23 1994-10-17 Airspray Int Bv Schuimvormingssamenstel, een daarvoor geschikte spuitkop en een spuitbus die een dergelijk samenstel omvat.
ES2068151B1 (es) 1993-06-23 1995-11-16 Cabrera Garrido Juan Microespuma inyectable para esclerosis.
US5623085A (en) 1994-09-23 1997-04-22 Rohm And Haas Company Method for reducing microfoam in a spray-applied waterborne composition
AU3896395A (en) 1994-10-11 1996-05-02 James A. Monson Dispensing apparatus for foaming compositions and method
GB9503119D0 (en) 1995-02-17 1995-04-05 Durand Ltd Medication and apparatus and method of applying medication
GB9823029D0 (en) 1998-10-22 1998-12-16 Giltech Ltd Packaging system
FR2775436A1 (fr) 1998-02-27 1999-09-03 Alain Monfreux Dispositif pour l'administration parenterale d'une composition sous forme d'une mousse
FR2775433A1 (fr) 1998-02-27 1999-09-03 Alain Monfreux Dispositif pour la production de mousse dans un corps de seringue
DE29819174U1 (de) 1998-10-28 1999-01-28 Kurt Vogelsang GmbH, 74855 Haßmersheim Schutzkappe für eine Zweikomponenten-Lack-Sprühdose
ES1043183Y (es) 1999-05-03 2000-04-01 Mingo Fco Javier Garcia Dispositivo para producir esclerosante espumado.
GB9912356D0 (en) 1999-05-26 1999-07-28 Btg Int Ltd Generation of microfoam
US6561237B1 (en) 2000-11-28 2003-05-13 Brasscorp Ltd. Apparatus and method for urging fluid into a pressurized system

Also Published As

Publication number Publication date
DE69418286D1 (de) 1999-06-10
ES2131689T7 (es) 2012-03-16
US5676962A (en) 1997-10-14
EP0656203B1 (en) 1999-05-06
DK0656203T3 (da) 1999-11-01
ES2068151A1 (es) 1995-04-01
DE69418286T2 (de) 1999-10-14
EP0656203A1 (en) 1995-06-07
GR3030248T3 (en) 1999-08-31
WO1995000120A1 (es) 1995-01-05
USRE38919E1 (en) 2005-12-13
ES2131689T3 (es) 1999-08-01
EP0656203B3 (en) 2011-01-26
USRE40640E1 (en) 2009-02-17
AU7001294A (en) 1995-01-17
ATE179598T1 (de) 1999-05-15

Similar Documents

Publication Publication Date Title
ES2068151B1 (es) Microespuma inyectable para esclerosis.
Bookstein et al. Pulsed-spray pharmacomechanical thrombolysis: preliminary clinical results
WO1994028781A3 (en) Magnetic resonance arteriography with dynamic intravenous contrast agents
DE3856096D1 (de) Verfahren zur Behandlung der mit dem Rauchstop verbundenen Entwöhnungssymptome sowie Mittel zur Verwendung in diesem Verfahren
ATE167400T1 (de) Lys-plasminogen in der verhütung und behandlung von ischämie und reperfusionschäden
ATE311192T1 (de) Verfahren zur behandlung von chronischen geschwüren
Georgiev Postsclerotherapy hyperpigmentations: chromated glycerin as a screen for patients at risk (a retrospective study)
KR900702018A (ko) 단백질과 핵산
ATE208216T1 (de) Verfahren zur herstellung von wirkstoffkomplexen
Ayyappan et al. Origin and Evolution of Sclerotherapy for Varicose Veins
GERSHUNI et al. Decompression of an experimental compartment syndrome in dogs with hyaluronidase
RU95113856A (ru) Способ лечения окклюзирующих поражений сосудов сетчатки и зрительного нерва
RU93052523A (ru) Способ лечения орхоэпидидимита
FR2300574A2 (fr) Composition a base d'huile vegetale metabolisab
Dingwall et al. The use of sodium tetradecyl sulfate in the sclerosing treatment of varicose veins: An experimental and clinical study
US3137624A (en) Composition and method for treating defective veins
RU2000126214A (ru) Способ инъекционного лечения варикозного расширения вен нижних конечностей
Leu A rare case of angiodysplasia: penetration of inguinal lymph nodes by large superficial leg veins: Report of five cases
Maksimenko Complicated simplification of dosage regimen for plasminogen activators
Krüger New aspects of haemangioma treatment
Kersten Management of cosmetically objectionable periocular veins
Bernbach Compression Sclerotherapy
Strejcek et al. The Effect of Sclerotherapy on the Number of Circulating Endothelial Cells (CEC)
RU96114524A (ru) Способ лечения больных с лимфедемой конечностей
Bytka et al. Microcirculatory bed in chronic arterial obliteration